Actionnariat et activité des initiés pour Absci Corporation (ABSI): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $8.04 |
| Capitalisation | $1.4B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-31 | Jonasson Zachariah | F-InKind | 8,320 | $72K |
| 2026-03-03 | Somaratne Ransi Mudalinayake | A-Award | 650,000 | $1.7M |
| 2026-08-03 | Somaratne Ransi Mudalinayake | A-Award | 383,000 | $3.0M |
| 2026-03-03 | Somaratne Ransi Mudalinayake | |||
| 2026-06-30 | Szela Mary T | P-Purchase | 12,900 | $149K |
| 2026-06-24 | McClain Sean | F-InKind | 59,896 | $603K |
| 2026-06-04 | Szela Mary T | A-Award | 33,200 | $244K |
| 2026-06-04 | Szela Mary T | A-Award | 8,400 | |
| 2026-06-04 | MCGINNIS KAREN K | A-Award | 10,100 | |
| 2026-06-04 | MCGINNIS KAREN K | A-Award | 39,800 | $292K |
Bilan (10 ans)
| Année | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Trésorerie | $13.1M | $69.9M | $252.6M | $60.0M | $72.4M | $41.2M | $20.0M |
| Placements à Court Terme | 0 | 0 | 0 | $104.5M | $25.3M | $71.2M | $124.3M |
| Créances | $222000 | $1.6M | $1.4M | $1.6M | $2.2M | 0 | 0 |
| Stocks | 0 | 0 | $10.5M | $15.0M | 0 | 0 | 0 |
| Actifs Courants | $13.6M | $73.2M | $273.1M | $186.9M | $120.6M | $133.8M | $149.6M |
| Immobilisations Corporelles | $5.0M | $13.4M | $58.7M | $58.0M | $45.8M | $33.1M | $23.8M |
| Goodwill | 0 | 0 | $21.3M | $21.3M | 0 | 0 | 0 |
| Actifs Incorporels | $283000 | 0 | $55.0M | $51.6M | $48.3M | $44.9M | $41.5M |
| Actifs Totaux | $19.5M | $88.6M | $426.2M | $321.0M | $217.3M | $213.6M | $216.3M |
| Dettes Fournisseurs | $268000 | $2.1M | $8.4M | $2.4M | $1.5M | $3.5M | $2.8M |
| Dette à Court Terme | $1.2M | $1.5M | $2.4M | $2.9M | $3.3M | $2.7M | $873000 |
| Passifs Courants | $3.5M | $10.1M | $33.9M | $30.3M | $29.6M | $28.7M | $22.8M |
| Dette à Long Terme | $1.7M | $4.1M | $1.1M | $8.0M | $4.7M | $1.3M | 0 |
| Passifs Totaux | $60.6M | $21.6M | $60.1M | $46.6M | $41.1M | $34.5M | $26.8M |
| Réserves | -$41.4M | -$90.1M | -$191.0M | -$295.9M | -$406.5M | -$509.6M | -$624.8M |
| Capitaux Propres | -$41.2M | $67.0M | $366.1M | $274.4M | $176.2M | $179.1M | $189.4M |
| Dette Totale | $6.0M | $14.5M | $20.0M | $23.0M | $15.9M | $10.1M | $5.3M |
| Dette Nette | -$7.1M | -$55.4M | -$232.6M | -$141.4M | -$81.8M | -$102.3M | -$139.0M |
| Fonds de Roulement | $10.2M | $63.1M | $239.2M | $156.6M | $91.0M | $105.2M | $126.8M |
Santé financière
| Dette / Capitaux propres | 0.01 |
| Ratio de liquidité | 10.63 |
Rentabilité
| Rentabilité des capitaux propres | -59.21% |
| Rentabilité du capital investi | -52.24% |
| Rentabilité des actifs | -45.02% |
| Marge brute | -255.93% |
| Marge opérationnelle | -8411.27% |
| Marge nette | -7756.37% |
Entreprises liées: CRVS · ERAS · GOSS · MGTX · MLTX · OLMA · PRTA
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ABSI: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions